JP2004002433A5 -

Download PDF

Info

Application number

JP2003156493A

Other languages

Other versions

Filing date

2003-06-02

Publication date

2007-03-29

2003-06-02 Application filed filed Critical

2003-06-02 Priority to JP2003156493A priority Critical patent/JP4574959B2/ja

2003-06-02 Priority claimed from JP2003156493A external-priority patent/JP4574959B2/ja

2004-01-08 Publication of JP2004002433A publication Critical patent/JP2004002433A/ja

2007-03-29 Publication of JP2004002433A5 publication Critical patent/JP2004002433A5/ja

2010-11-04 Application granted granted Critical

2010-11-04 Publication of JP4574959B2 publication Critical patent/JP4574959B2/ja

2019-12-07 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 3
101710200814 Melanotropin alpha Proteins 0.000 description 3
238000000034 method Methods 0.000 description 3
WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 3
206010061218 Inflammation Diseases 0.000 description 2
230000005856 abnormality Effects 0.000 description 2
239000002537 cosmetic Substances 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
235000021374 legumes Nutrition 0.000 description 2
230000019612 pigmentation Effects 0.000 description 2
239000002798 polar solvent Substances 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1

JP2003156493A 2003-06-02 2003-06-02 α−ＭＳＨ抑制用の皮膚外用剤 Expired - Fee Related JP4574959B2 (ja)